Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor
about
11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice.11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery.Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease.Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.On-column ligand exchange for structure-based drug design: a case study with human 11β-hydroxysteroid dehydrogenase type 1.2-Allylaminothiazole and 2-allylaminodihydrothiazole derivatives: synthesis, characterization, and evaluation of bioactivity.Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle.Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
P2860
Q34253331-AD92E95B-66C9-460B-941F-80EA821AC431Q36211201-29A9EF9F-5178-4365-A5A0-BEFA91CDA2D2Q37489938-B617F703-F0D6-443A-82BF-72F0B2B33998Q37859010-8FFE45DD-EFD3-443A-A393-2C8B51C6CC70Q38016165-29AC5FFE-1BDC-4FB7-BF04-9F445C87B93AQ39702137-61860827-49B8-4385-B613-C15D01D95B97Q41844272-AD7BFE0D-E8F4-4EA5-B75E-BDB71EB4B886Q41960701-36E32A99-D255-41E9-8EB3-604B78391EE0Q42449550-AC88EAFF-FABD-469F-A413-07478CAD9611Q46596334-36D3EF7B-3EC2-4BCB-9D5A-744A28584F52Q58896395-B99A1102-E56E-4577-9925-E4B1922AAEEF
P2860
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structural characterization an ...... dehydrogenase type 1 inhibitor
@ast
Structural characterization an ...... dehydrogenase type 1 inhibitor
@en
Structural characterization an ...... dehydrogenase type 1 inhibitor
@nl
type
label
Structural characterization an ...... dehydrogenase type 1 inhibitor
@ast
Structural characterization an ...... dehydrogenase type 1 inhibitor
@en
Structural characterization an ...... dehydrogenase type 1 inhibitor
@nl
prefLabel
Structural characterization an ...... dehydrogenase type 1 inhibitor
@ast
Structural characterization an ...... dehydrogenase type 1 inhibitor
@en
Structural characterization an ...... dehydrogenase type 1 inhibitor
@nl
P2093
P921
P1476
Structural characterization an ...... dehydrogenase type 1 inhibitor
@en
P2093
Athena Sudom
Christopher Fotsch
Clarence Hale
David J St Jean
Dean Hickman
Guy Matsumoto
Jocelyn McCormick
Michelle Chen
Minghan Wang
P356
10.1111/J.1747-0285.2007.00603.X
P577
2008-01-01T00:00:00Z